Blackstone (NYSE:BX) names Mark
McClellan, a physician and economist who served as both commissioner of
the U.S. Food and Drug Administration and administrator of the Centers
for Medicare and Medicaid Services, as a senior adviser.
He’ll advise on life sciences, healthcare,
economics and public policy sectors, with a focus on Blackstone Growth
and Blackstone Life Sciences.
“The current environment has only underscored the
importance of long-term investment in the healthcare sector and we
believe private capital can play a critical role,” said John Korngold,
global head of Blackstone Growth, in a statement.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.